| Free Cash Flow |
$14.20M |
$22.55M |
$28.50M |
$33.98M |
$18.95M |
| -Change In Other Working Capital |
$6.24M |
-$130,000.00 |
$24.68M |
$1.65M |
$957,000.00 |
| -Change in Other Current Liabilities |
-$2.09M |
-$2.60M |
– |
– |
-$2.29M |
| -Change in Prepaid Assets |
-$5.45M |
$1.81M |
-$1.69M |
-$3.56M |
$696,000.00 |
| -Change in Receivables |
-$17.29M |
$23.25M |
-$33.51M |
$1.93M |
-$8.91M |
| Change in Working Capital |
-$7.01M |
-$870,000.00 |
$402,000.00 |
$7.71M |
-$1.38M |
| Other Non-Cash Items |
$4.25M |
$2.52M |
$2.60M |
$1.09M |
$2.55M |
| Deferred Tax |
-$20.06M |
-$115,000.00 |
$1.38M |
-$3.46M |
-$60,000.00 |
| Depreciation & Depletion & Amortization |
$1.72M |
$1.66M |
$1.56M |
$1.52M |
$1.62M |
| Gain/Loss from Continuing Operations |
-$108,000.00 |
-$1.45M |
$195,000.00 |
$249,000.00 |
$3.51M |
| Net Income from Continuing Operations |
$27.57M |
$15.25M |
$15.64M |
$13.02M |
$2.89M |
| Net cash flow from continuing operations |
$15.94M |
$24.26M |
$29.66M |
$34.83M |
$20.27M |
| Operating Cash Flow |
$15.94M |
$24.26M |
$29.66M |
$34.83M |
$20.27M |
| Net cash flow from investing |
-$1.83M |
-$1.60M |
$10.99M |
-$13.01M |
-$1.33M |
| Net Cash Flow from Continuing Investing Activities |
-$1.83M |
-$1.60M |
$10.99M |
-$13.01M |
-$1.33M |
| Capital Expenditure |
-$533,000.00 |
-$432,000.00 |
-$462,000.00 |
-$350,000.00 |
-$360,000.00 |
| -Change in Payables and Accrued Expense |
$11.58M |
-$23.20M |
$19.55M |
$3.56M |
$8.17M |
| Effect of Exchange Rate Changes |
-$182,000.00 |
-$712,000.00 |
$237,000.00 |
-$814,000.00 |
$925,000.00 |
| Beginning Cash Balance |
$444.14M |
$481.06M |
$471.64M |
$429.82M |
$351.48M |
| Net Change in Cash |
-$26.70M |
-$36.21M |
$9.18M |
$42.64M |
$77.41M |
| Ending Cash Balance |
$417.25M |
$444.14M |
$481.06M |
$471.64M |
$429.82M |
| Net Other Financing Charges |
-$1.84M |
-$2,000.00 |
-$18.22M |
$18.21M |
-$12.15M |
| Proceeds from Stock Option Exercised |
$11.54M |
$942,000.00 |
$9.19M |
$10.95M |
$77.66M |
| Net Common Stock Issuance |
-$50.52M |
-$59.81M |
-$22.44M |
-$8.36M |
-$7.05M |
| Net Cash Flow from Continuing Financing Activities |
-$40.82M |
-$58.87M |
-$31.47M |
$20.81M |
$58.47M |
| Financing Cash Flow |
-$40.82M |
-$58.87M |
-$31.47M |
$20.81M |
$58.47M |
| Net Investment Purchase and Sale |
-$88,000.00 |
$105,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Business Purchase and Sale |
$0.00 |
$0.00 |
$12.15M |
-$12.15M |
$0.00 |
| Net PPE Purchase and Sale |
-$1.21M |
-$1.28M |
-$697,000.00 |
-$507,000.00 |
-$965,000.00 |
| Net Issuance Payments Of Debt |
– |
– |
– |
-$1,000.00 |
– |
No comments yet — be the first to weigh in on AVPT.